15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 17 firms covering Morgan Stanley, 9 rate it Buy or better, 7 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $186.00 to $262.00, a moderate spread. The average target of $233.07 sits 10% above the current $211.78. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.93 next quarter toward $13.59 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 ratings
Moderate Buy
Strong Buy00%
Buy953%
Hold741%
Sell16%
Strong Sell00%
Based on 17 analysts giving stock ratings to Morgan Stanley.
As of Jul, 9 of 17 firms rate MS a Buy (7 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
MS EPS & revenue forecast
EPS · NEXT QUARTER
$2.93
Range $2.62 – $3.43 · 14 analysts · +9% YoY
Next period, 14 analysts expect Morgan Stanley to earn $2.93 a share (range $2.62 – $3.43), versus $2.68 a year earlier. Full-year consensus is $12.97, growing to $13.59 the year after.
REVENUE · NEXT QUARTER
$20.5B
Range $19.6B – $22.1B · 14 analysts · +15% YoY
Revenue is expected to reach $20.5B (range $19.6B – $22.1B), +14.7% year-over-year. Full-year consensus is $82.7B, rising to $86.1B next year.
Top analysts covering Morgan Stanley
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MS.
#1
Chris Kotowski
Oppenheimer · Rank #98
Sell
No targeton MS
Overall win rate
45%
+ Follow
#2
Glenn Schorr
Evercore ISI Group
Buy
$240.00+13.3% to target
Coverage
—
+ Follow
#3
KA
Kian Abouhossein
JP Morgan
Hold
$195.00-7.9% to target
Coverage
—
+ Follow
#4
Mike Mayo
Wells Fargo
Hold
$240.00+13.3% to target
Coverage
—
+ Follow
#5
Jason Goldberg
Barclays
Buy
$262.00+23.7% to target
Coverage
—
+ Follow
MS stock forecast FAQ
What is MS's average 12-month price target?+
The 14 analysts with a live target average $233.07 for Morgan Stanley over the next 12 months, ranging from a $262.00 high to a $186.00 low.
Is MS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 17 analyst ratings, 9 are Buy or Strong Buy, 7 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for MS?+
The Street-high target is $262.00 (Barclays), and the Street-low is $186.00 (Jefferies). The average of all 14 active targets is $233.07.
How many Wall Street analysts cover MS?+
17 analysts have an active rating on Morgan Stanley, and 14 firms carry a live 12-month price target.
Who is the most accurate analyst covering MS?+
Among analysts who currently cover MS, Chris Kotowski of Oppenheimer has the strongest overall Quantellect track record (Rank #98). Their current call is Sell.
What is Morgan Stanley's projected EPS for next quarter?+
The consensus estimate is $2.93 per share (range $2.62 – $3.43) across 14 analysts. Full-year EPS is projected at $12.97, rising to $13.59 the following year.
How much revenue is Morgan Stanley expected to report next quarter?+
Consensus revenue is $20.5B (range $19.6B – $22.1B). Full-year revenue is projected at $82.7B, growing to $86.1B next year.
Have analysts been upgrading or downgrading MS lately?+
As of Jul, 9 of 17 firms rate MS a Buy (7 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.